Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins

…, M Hermann, M Deckert, D Von Laer - Human gene …, 2004 - liebertpub.com
Malignant gliomas are the most frequent primary brain tumors and have a dismal prognosis
due to their infiltrative growth. Gene therapy using viral vectors represents an attractive …

[HTML][HTML] SARS-CoV-2 Omicron variant neutralization in serum from vaccinated and convalescent persons

…, L Riepler, D Bante, D von Laer… - New England Journal …, 2022 - Mass Medical Soc
In Vitro Neutralization of Omicron Variant Serum from vaccinated persons was assayed for
ability to neutralize the omicron variant of SARS-CoV-2. Persons who had received two doses …

Gene therapy for HIV infection: what does it need to make it work?

D von Laer, S Hasselmann… - The Journal of Gene …, 2006 - Wiley Online Library
The efficacy of antiviral drug therapy for HIV infection is limited by toxicity and viral resistance.
Thus, alternative therapies need to be explored. Several gene therapeutic strategies for …

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors

…, F Costacurta, MA Esler, H Aihara, D von Laer… - Science …, 2023 - science.org
Vaccines and drugs have helped reduce disease severity and blunt the spread of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). However, ongoing virus transmission…

TK. 007: A novel, codon-optimized HSVtk (A168H) mutant for suicide gene therapy

…, U Felldin, E Alici, G Gahrton, D von Laer… - Human gene …, 2010 - liebertpub.com
Conditional elimination of infused gene-modified alloreactive T cells, using suicide gene
activation, has been shown to be an efficient strategy to abrogate severe graft-versus-host …

Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2

…, M Nairz, G Weiss, MT Wolfinger, D von Laer… - Science translational …, 2020 - science.org
Superspreading events shaped the coronavirus disease 2019 (COVID-19) pandemic, and
their rapid identification and containment are essential for disease control. Here, we provide a …

SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376

…, B Rupp, L Martinez-Sobrido, D von Laer - Science translational …, 2022 - science.org
Protease inhibitors are among the most powerful antiviral drugs. Nirmatrelvir is the first
protease inhibitor specifically developed against the SARS-CoV-2 protease 3CL pro that has …

[HTML][HTML] Neutralization profile after recovery from SARS-CoV-2 omicron infection

A Rössler, L Knabl, D von Laer… - New England Journal of …, 2022 - Mass Medical Soc
Convalescent Antibodies after Omicron Infection Although considerable data show cross-reactivity
among antibodies generated by infection with the various SARS-CoV-2 variants of …

Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P

WR Beyer, D Pöpplau, W Garten, D von Laer… - Journal of …, 2003 - Am Soc Microbiol
The envelope glycoprotein (GP) of lymphocytic choriomeningitis virus (LCMV) is posttranslationally
cleaved into two subunits. We show here that this endoproteolytic processing is not …

[HTML][HTML] Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1

…, M Wiesel, M Ibberson, I Xenarios, D Von Laer… - Immunity, 2014 - cell.com
Direct type I interferon (IFN) signaling on T cells is necessary for the proper expansion,
differentiation, and survival of responding T cells following infection with viruses prominently …